BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. GATA1, Response to oxidative stress, HIV infection, Hypothalamus, Avian flu virus)
Bookmark Forward

QuickView for CD38 (gene)


Body Atlas

Most Correlated Tissues

  1. Plasma cell of spleen
  2. Thymus gland
  3. Prostate gland
  4. Hematopoietic stem cell of bone marrow
  5. Bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Zinc deficiency
  2. Salmonella infection
  3. Spotted fevers
  4. Bacterial infection due to Bacillus
  5. Protozoan infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 2-(4-(pyridin-4-yl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)phenoxymethyl)quinoline succinic acid
  2. HIV Protease Inhibitors
  3. FluLaval
  4. TX 522
  5. fluarix
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CFLAR
  2. SALL1
  3. MAPK6
  4. MGMT
  5. MYD88
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The potential of CD38 protein as a target for autoimmune diseases.
  2. CD38-mediated oxytocin signaling in paraventricular nucleus contributes to empathic pain.
  3. Evaluation of diagnostic potential of CD38 in rickets.
  4. Application of CD38 monoclonal antibody in kidney disease.
  5. Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
  2. Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies
  3. Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
  4. A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relaps…
  5. A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.